Medicare Enrolled
Dr. Nenad Serafimovski, MD
Cardiovascular Disease · Southfield, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Serafimovski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Serafimovski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Serafimovski
Dr. Nenad Serafimovski is a cardiovascular disease specialist in Southfield, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Serafimovski performed 2,105 Medicare services across 1,417 unique beneficiaries.
Between the years covered by Open Payments, Dr. Serafimovski received a total of $3,861 from 29 pharmaceutical and/or device companies across 103 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Serafimovski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 29% volume in MI
$3,861 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,105
Medicare services
Top 29% in MI for cardiovascular disease
1,417
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~111 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
370 | $64 | $203 |
| Ultrasound of heart An imaging test that uses sound waves to create pictures of the heart's structure and function. |
258 | $34 | $112 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
252 | $7 | $19 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
144 | $141 | $445 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
126 | $50 | $160 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
101 | $67 | $226 |
| Injection, dipyridamole, per 10 mg | 93 | $3 | $5 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
82 | $41 | $121 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
80 | $97 | $306 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
59 | $38 | $124 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
56 | $44 | $250 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
42 | $108 | $224 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
39 | $137 | $464 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
33 | $240 | $770 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
32 | $52 | $281 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
32 | $55 | $307 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
31 | $16 | $52 |
| Venipuncture for blood draw Insertion of a needle into a vein to collect blood samples. This procedure is performed on patients aged 3 years or older. |
28 | $14 | $30 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
28 | $29 | $350 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $144 | $460 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
26 | $11 | $62 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
26 | $20 | $62 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
24 | $84 | $228 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
23 | $14 | $38 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
23 | $2 | $7 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
20 | $8 | $15 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
15 | $11 | $107 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
12 | $11 | $31 |
| Coronary angiography A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels. |
12 | $185 | $505 |
| Transesophageal echocardiogram during heart surgery An ultrasound of the heart performed using a probe inserted into the esophagus while surgery on the heart or major blood vessels is taking place, including a written report. |
11 | $180 | $472 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.5% high complexity
33.7% medium
62.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,861
Total received (2018-2024)
Avg $552/year across 7 years
Top 42% in MI for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
103
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,673 (95.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$188 (4.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,361
2023
$1,017
2022
$781
2021
$225
2020
$195
2019
$37
2018
$245
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$249
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$231
AstraZeneca Pharmaceuticals LP
$229
Lilly USA, LLC
$151
Bayer Healthcare Pharmaceuticals Inc.
$125
Abbott Laboratories
$100
Actelion Pharmaceuticals US, Inc.
$80
Kiniksa Pharmaceuticals International, plc
$76
American Regent
$32
UCB, Inc.
$31
LANTHEUS MEDICAL IMAGING, INC.
$20
Lexicon Pharmaceuticals, Inc.
$20
ABIOMED
$16
Top 3 companies account for 52.1% of 2024 payments
All-time payments by company (2018-2024) ›
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$594
AstraZeneca Pharmaceuticals LP
$461
Janssen Pharmaceuticals, Inc
$346
Boehringer Ingelheim Pharmaceuticals, Inc.
$249
Abbott Laboratories
$218
Novartis Pharmaceuticals Corporation
$190
Astellas Pharma US Inc
$188
Bayer HealthCare Pharmaceuticals Inc.
$185
Kestra Medical Technology Services, Inc.
$179
Novo Nordisk Inc
$176
Lilly USA, LLC
$151
Bayer Healthcare Pharmaceuticals Inc.
$125
Cardiovascular Systems Inc.
$120
Actelion Pharmaceuticals US, Inc.
$116
Merck Sharp & Dohme LLC
$101
Medtronic Vascular, Inc.
$101
Kiniksa Pharmaceuticals International, plc
$76
PFIZER INC.
$38
Amarin Pharma Inc.
$37
American Regent
$32
UCB, Inc.
$31
CARDIVA MEDICAL, INC.
$25
Bardy Diagnostics, Inc.
$24
LANTHEUS MEDICAL IMAGING, INC.
$20
Lexicon Pharmaceuticals, Inc.
$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
ABIOMED
$16
ConvaTec Inc.
$13
Eisai Inc.
$11
Top 3 companies account for 36.3% of all-time payments
Associated products mentioned in payments ›
AMPLATZER AMULET · AQUACEL Ag Surgical · Adempas · Arcalyst · Assure WCD · BRILINTA · Belviq · CARDIVA VASCADE MVP VVCS 6-12F · Carnation Ambulatory Monitor · Claria MRI · DEFINITY · Diamondback Peripheral · ELIQUIS · ENTRESTO · FARXIGA · INJECTAFER · Impella · JARDIANCE · Kerendia · LEQVIO · LifeVest · MOUNJARO · Nayzilam · OPSUMIT · Ozempic · Rybelsus · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · WAINUA · XARELTO · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
320
Per 100K population
25.2
County median income
$95,296
Nearest hospital
STRAITH HOSPITAL FOR SPECIAL SURGERY
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Serafimovski is a mixed practice specialist, with above-average Medicare volume (top 29% in MI), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Serafimovski experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Serafimovski performed 370 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Serafimovski receive payments from pharmaceutical companies?
Yes. Dr. Serafimovski received a total of $3,861 from 29 companies across 103 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Serafimovski's costs compare to other cardiologists in Southfield?
Dr. Serafimovski's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Serafimovski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Southfield
Browse cardiologists in Southfield ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in MI
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in MI
Which MI cardiologists receive the most from drug and device companies.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology